GI Innovation Inc
KOSDAQ:358570
GI Innovation Inc
Net Income (Common)
GI Innovation Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
GI Innovation Inc
KOSDAQ:358570
|
Net Income (Common)
-₩79.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Celltrion Inc
KRX:068270
|
Net Income (Common)
₩392.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Net Income (Common)
₩22.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Net Income (Common)
₩97.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Net Income (Common)
₩76.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Net Income (Common)
-₩3.4B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is GI Innovation Inc's Net Income (Common)?
Net Income (Common)
-79.8B
KRW
Based on the financial report for Dec 31, 2022, GI Innovation Inc's Net Income (Common) amounts to -79.8B KRW.
What is GI Innovation Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
47%
Over the last year, the Net Income (Common) growth was 47%.